These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 23042786)

  • 1. The FTD/ALS-associated RNA-binding protein TDP-43 regulates the robustness of neuronal specification through microRNA-9a in Drosophila.
    Li Z; Lu Y; Xu XL; Gao FB
    Hum Mol Genet; 2013 Jan; 22(2):218-25. PubMed ID: 23042786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frontotemporal dementia and amyotrophic lateral sclerosis-associated disease protein TDP-43 promotes dendritic branching.
    Lu Y; Ferris J; Gao FB
    Mol Brain; 2009 Sep; 2():30. PubMed ID: 19781077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of microRNA-9 in iPSC-derived neurons of FTD/ALS patients with TDP-43 mutations.
    Zhang Z; Almeida S; Lu Y; Nishimura AL; Peng L; Sun D; Wu B; Karydas AM; Tartaglia MC; Fong JC; Miller BL; Farese RV; Moore MJ; Shaw CE; Gao FB
    PLoS One; 2013; 8(10):e76055. PubMed ID: 24143176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuronal function and dysfunction of Drosophila dTDP.
    Lin MJ; Cheng CW; Shen CK
    PLoS One; 2011; 6(6):e20371. PubMed ID: 21673800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapamycin alleviates pathogenesis of a new Drosophila model of ALS-TDP.
    Cheng CW; Lin MJ; Shen CK
    J Neurogenet; 2015; 29(2-3):59-68. PubMed ID: 26219309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TDP-43-mediated neurodegeneration: towards a loss-of-function hypothesis?
    Vanden Broeck L; Callaerts P; Dermaut B
    Trends Mol Med; 2014 Feb; 20(2):66-71. PubMed ID: 24355761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The emerging roles of microRNAs in the pathogenesis of frontotemporal dementia-amyotrophic lateral sclerosis (FTD-ALS) spectrum disorders.
    Gascon E; Gao FB
    J Neurogenet; 2014; 28(1-2):30-40. PubMed ID: 24506814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrotransposon activation contributes to neurodegeneration in a Drosophila TDP-43 model of ALS.
    Krug L; Chatterjee N; Borges-Monroy R; Hearn S; Liao WW; Morrill K; Prazak L; Rozhkov N; Theodorou D; Hammell M; Dubnau J
    PLoS Genet; 2017 Mar; 13(3):e1006635. PubMed ID: 28301478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysregulation of the ALS-associated gene TDP-43 leads to neuronal death and degeneration in mice.
    Igaz LM; Kwong LK; Lee EB; Chen-Plotkin A; Swanson E; Unger T; Malunda J; Xu Y; Winton MJ; Trojanowski JQ; Lee VM
    J Clin Invest; 2011 Feb; 121(2):726-38. PubMed ID: 21206091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drosophila lines with mutant and wild type human TDP-43 replacing the endogenous gene reveals phosphorylation and ubiquitination in mutant lines in the absence of viability or lifespan defects.
    Chang JC; Morton DB
    PLoS One; 2017; 12(7):e0180828. PubMed ID: 28686708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ALS-associated proteins FUS and TDP-43 function together to affect Drosophila locomotion and life span.
    Wang JW; Brent JR; Tomlinson A; Shneider NA; McCabe BD
    J Clin Invest; 2011 Oct; 121(10):4118-26. PubMed ID: 21881207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of mutant TDP-43 induces neuronal dysfunction in transgenic mice.
    Xu YF; Zhang YJ; Lin WL; Cao X; Stetler C; Dickson DW; Lewis J; Petrucelli L
    Mol Neurodegener; 2011 Oct; 6():73. PubMed ID: 22029574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Both cytoplasmic and nuclear accumulations of the protein are neurotoxic in Drosophila models of TDP-43 proteinopathies.
    Miguel L; Frébourg T; Campion D; Lecourtois M
    Neurobiol Dis; 2011 Feb; 41(2):398-406. PubMed ID: 20951205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The inhibition of TDP-43 mitochondrial localization blocks its neuronal toxicity.
    Wang W; Wang L; Lu J; Siedlak SL; Fujioka H; Liang J; Jiang S; Ma X; Jiang Z; da Rocha EL; Sheng M; Choi H; Lerou PH; Li H; Wang X
    Nat Med; 2016 Aug; 22(8):869-78. PubMed ID: 27348499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coexistence of perseveration and apathy in the TDP-43
    Kim E; White MA; Phillips BU; Lopez-Cruz L; Kim H; Heath CJ; Lee JE; Saksida LM; Sreedharan J; Bussey TJ
    Transl Psychiatry; 2020 Nov; 10(1):377. PubMed ID: 33149110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drosophila Ref1/ALYREF regulates transcription and toxicity associated with ALS/FTD disease etiologies.
    Berson A; Goodman LD; Sartoris AN; Otte CG; Aykit JA; Lee VM; Trojanowski JQ; Bonini NM
    Acta Neuropathol Commun; 2019 Apr; 7(1):65. PubMed ID: 31036086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia.
    Mackenzie IR; Rademakers R; Neumann M
    Lancet Neurol; 2010 Oct; 9(10):995-1007. PubMed ID: 20864052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrovirus reactivation in CHMP2BIntron5 models of frontotemporal dementia.
    Fort-Aznar L; Ugbode C; Sweeney ST
    Hum Mol Genet; 2020 Sep; 29(16):2637-2646. PubMed ID: 32628265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Drosophila model for TDP-43 proteinopathy.
    Li Y; Ray P; Rao EJ; Shi C; Guo W; Chen X; Woodruff EA; Fushimi K; Wu JY
    Proc Natl Acad Sci U S A; 2010 Feb; 107(7):3169-74. PubMed ID: 20133767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS/FTD.
    Chou CC; Zhang Y; Umoh ME; Vaughan SW; Lorenzini I; Liu F; Sayegh M; Donlin-Asp PG; Chen YH; Duong DM; Seyfried NT; Powers MA; Kukar T; Hales CM; Gearing M; Cairns NJ; Boylan KB; Dickson DW; Rademakers R; Zhang YJ; Petrucelli L; Sattler R; Zarnescu DC; Glass JD; Rossoll W
    Nat Neurosci; 2018 Feb; 21(2):228-239. PubMed ID: 29311743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.